Complete Remission in a Patient with Human Herpes Virus-8 Negative Multicentric Castleman Disease Using CHOP Chemotherapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder. Although MCD pathogenesis is unclear, studies have suggested that human herpesvirus 8 (HHV-8) may be associated with the disorder. Recent reports have identified MCD cases without viral infection. A 43-year-old woman presented to our hospital for fever and myalgia of 6 months’ duration. The complete blood count revealed an elevated leukocyte count (15.1x103/uL) and a decreased hemoglobin level of 10.0 g/dL. The C-reactive protein level was elevated at 276.5 mg/L. Thoracic computed tomography (CT) scans revealed bilateral axillary lymphadenopathy. There was no evidence of HHV-8, human immunodeficiency virus (HIV), or Mycobacterium infection. Histologic evaluation of a lymph node biopsy from the left axilla yielded a diagnosis of MCD. Cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) were administered for a total of 4 cycles. The patient’s fever and lymphadenopathy resolved after the course of chemotherapy. She has been in complete remission for 24 months at this writing. As previously reported, this case report suggests that MCD can develop without viral infection. CHOP chemotherapy may be an effective treatment option for newly diagnosed MCD patients.
Abstract
Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder. Although MCD pathogenesis is unclear, studies have suggested that human herpesvirus 8 (HHV-8) may be associated with the disorder. Recent reports have identified MCD cases without viral infection. A 43-year-old woman presented to our hospital for fever and myalgia of 6 months’ duration. The complete blood count revealed an elevated leukocyte count (15.1x103/uL) and a decreased hemoglobin level of 10.0 g/dL. The C-reactive protein level was elevated at 276.5 mg/L. Thoracic computed tomography (CT) scans revealed bilateral axillary lymphadenopathy. There was no evidence of HHV-8, human immunodeficiency virus (HIV), or Mycobacterium infection. Histologic evaluation of a lymph node biopsy from the left axilla yielded a diagnosis of MCD. Cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) were administered for a total of 4 cycles. The patient’s fever and lymphadenopathy resolved after the course of chemotherapy. She has been in complete remission for 24 months at this writing. As previously reported, this case report suggests that MCD can develop without viral infection. CHOP chemotherapy may be an effective treatment option for newly diagnosed MCD patients.
참고문헌 (15)
- Castleman B, "Localized mediastinal lymphnode hyperplasia resembling thymoma", Cancer, 9, pp.822~830 (1956)
- Ruco LP, "Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells", Histopathology, 19, pp.523~528 (1991)
- Keller AR, "Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations", Cancer, 29, pp.670~683 (1972)
- Gholam D, "A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody", Ann Hematol, 82, pp.766~768 (2003)
- Ide M, "Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab", Eur J Haematol, 76, pp.119~123 (2006)
- Frizzera G, "A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients", Am J Surg Pathol, 7, pp.211~231 (1983)
- Chang Y, "Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma", Science, 266, pp.1865~1869 (1994)
- Soulier J, "Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease", Blood, 86, pp.1276~1280 (1995)
- Aoki Y, "Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6", Blood, 93, pp.4034~4043 (1999)
- Nishi J, "Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node", Leuk Lymphoma, 38, pp.387~394 (2000)
- Berezne A, "Failure of cidofovir in HIV-associated multicentric Castleman disease", Blood, 103, pp.4368~4369 (2004)
- Marcelin AG, "Rituximab therapy for HIV-associated Castleman disease", Blood, 102, pp.2786~2788 (2003)
- Rieu P, "Retinoic acid for treatment of multicentric Castleman's disease", Lancet, 354, pp.1262~1263 (1999)
- Frizzera G, "A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients", J Clin Oncol, 3, pp.1202~1216 (1985)
- Scott D, "Treatment of HIV-associated multicentric Castleman's disease with oral etoposide", Am J Hematol, 66, pp.148~150 (2001)